Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH)
NCT04406870
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Hemangioendothelioma of Liver
Interventions
DRUG:
Sirolimus Oral Product
DRUG:
propranolol
Sponsor
Shanghai Children's Medical Center